Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Marbofloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Marbofloxacin, including repackagers and relabelers. The FDA regulates Marbofloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Marbofloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Marbofloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Marbofloxacin supplier is an individual or a company that provides Marbofloxacin active pharmaceutical ingredient (API) or Marbofloxacin finished formulations upon request. The Marbofloxacin suppliers may include Marbofloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of Marbofloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Marbofloxacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Marbofloxacin active pharmaceutical ingredient (API) in detail. Different forms of Marbofloxacin DMFs exist exist since differing nations have different regulations, such as Marbofloxacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Marbofloxacin DMF submitted to regulatory agencies in the US is known as a USDMF. Marbofloxacin USDMF includes data on Marbofloxacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Marbofloxacin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Marbofloxacin suppliers with USDMF on PharmaCompass.
A Marbofloxacin CEP of the European Pharmacopoeia monograph is often referred to as a Marbofloxacin Certificate of Suitability (COS). The purpose of a Marbofloxacin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Marbofloxacin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Marbofloxacin to their clients by showing that a Marbofloxacin CEP has been issued for it. The manufacturer submits a Marbofloxacin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Marbofloxacin CEP holder for the record. Additionally, the data presented in the Marbofloxacin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Marbofloxacin DMF.
A Marbofloxacin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Marbofloxacin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Marbofloxacin suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Marbofloxacin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Marbofloxacin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Marbofloxacin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Marbofloxacin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Marbofloxacin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Marbofloxacin suppliers with NDC on PharmaCompass.
Marbofloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Marbofloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Marbofloxacin GMP manufacturer or Marbofloxacin GMP API supplier for your needs.
A Marbofloxacin CoA (Certificate of Analysis) is a formal document that attests to Marbofloxacin's compliance with Marbofloxacin specifications and serves as a tool for batch-level quality control.
Marbofloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Marbofloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Marbofloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Marbofloxacin EP), Marbofloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Marbofloxacin USP).
LOOKING FOR A SUPPLIER?
